Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$307,484
-$135,338 QoQ
Shares Held
1,962
-32.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,118
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intellectus Partners, LLC holds $12,763,770 across 10 Drug Manufacturers - General names. NVS ranks #10 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
11,595 | $2,917,765 | |
| 2 | LLY |
ELI LILLY & Co
|
1,918 | $2,300,506 | |
| 3 | NVO |
Novo Nordisk A S
|
33,631 | $1,612,270 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,435 | $1,212,397 | |
| 5 | PFE |
Pfizer Inc
|
48,637 | $1,171,178 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,947 | $1,130,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,002 | $979,655 | |
| 8 | JNJ |
Johnson & Johnson
|
2,801 | $711,369 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $307,484 | 1,962 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $442,822 | 2,899 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $532,040 | 3,859 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $581,953 | 4,538 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $549,143 | 4,538 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $505,896 | 4,538 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $404,906 | 4,161 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $490,100 | 4,261 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $462,249 | 4,342 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $457,145 | 4,726 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $477,184 | 4,726 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $481,390 | 4,726 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $476,900 | 4,726 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $587,972 | 6,391 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $594,034 | 6,548 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $430,900 | 5,669 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $479,200 | 5,669 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $528,430 | 6,022 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $524,994 | 6,002 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $496,568 | 6,072 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $554,100 | 6,073 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $519,718 | 6,080 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $578,950 | 6,131 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $542,891 | 6,243 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $593,125 | 6,791 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $559,917 | 6,791 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||